Automated Machine Learning in Predicting 30-Day Mortality in Patients with Non-Cholestatic Cirrhosis

Objective: To evaluate the feasibility of automated machine learning (AutoML) in predicting 30-day mortality in non-cholestatic cirrhosis. Methods: A total of 932 cirrhotic patients were included from the First Affiliated Hospital of Soochow University between 2014 and 2020. Participants were divide...

Full description

Bibliographic Details
Main Authors: Chenyan Yu, Yao Li, Minyue Yin, Jingwen Gao, Liting Xi, Jiaxi Lin, Lu Liu, Huixian Zhang, Airong Wu, Chunfang Xu, Xiaolin Liu, Yue Wang, Jinzhou Zhu
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/12/11/1930
_version_ 1797464848695558144
author Chenyan Yu
Yao Li
Minyue Yin
Jingwen Gao
Liting Xi
Jiaxi Lin
Lu Liu
Huixian Zhang
Airong Wu
Chunfang Xu
Xiaolin Liu
Yue Wang
Jinzhou Zhu
author_facet Chenyan Yu
Yao Li
Minyue Yin
Jingwen Gao
Liting Xi
Jiaxi Lin
Lu Liu
Huixian Zhang
Airong Wu
Chunfang Xu
Xiaolin Liu
Yue Wang
Jinzhou Zhu
author_sort Chenyan Yu
collection DOAJ
description Objective: To evaluate the feasibility of automated machine learning (AutoML) in predicting 30-day mortality in non-cholestatic cirrhosis. Methods: A total of 932 cirrhotic patients were included from the First Affiliated Hospital of Soochow University between 2014 and 2020. Participants were divided into training and validation datasets at a ratio of 8.5:1.5. Models were developed on the H<sub>2</sub>O AutoML platform in the training dataset, and then were evaluated in the validation dataset by area under receiver operating characteristic curves (AUC). The best AutoML model was interpreted by SHapley Additive exPlanation (SHAP) Plot, Partial Dependence Plots (PDP), and Local Interpretable Model Agnostic Explanation (LIME). Results: The model, based on the extreme gradient boosting (XGBoost) algorithm, performed better (AUC 0.888) than the other AutoML models (logistic regression 0.673, gradient boost machine 0.886, random forest 0.866, deep learning 0.830, stacking 0.850), as well as the existing scorings (the model of end-stage liver disease [MELD] score 0.778, MELD-Na score 0.782, and albumin-bilirubin [ALBI] score 0.662). The most key variable in the XGBoost model was high-density lipoprotein cholesterol, followed by creatinine, white blood cell count, international normalized ratio, etc. Conclusion: The AutoML model based on the XGBoost algorithm presented better performance than the existing scoring systems for predicting 30-day mortality in patients with non-cholestatic cirrhosis. It shows the promise of AutoML in its future medical application.
first_indexed 2024-03-09T18:13:59Z
format Article
id doaj.art-9d4bc37de0aa4d629523783c0b33303f
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-09T18:13:59Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-9d4bc37de0aa4d629523783c0b33303f2023-11-24T08:54:40ZengMDPI AGJournal of Personalized Medicine2075-44262022-11-011211193010.3390/jpm12111930Automated Machine Learning in Predicting 30-Day Mortality in Patients with Non-Cholestatic CirrhosisChenyan Yu0Yao Li1Minyue Yin2Jingwen Gao3Liting Xi4Jiaxi Lin5Lu Liu6Huixian Zhang7Airong Wu8Chunfang Xu9Xiaolin Liu10Yue Wang11Jinzhou Zhu12Department of Gastroenterology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Gastroenterology, Dushu Lake Hospital Affiliated to Soochow University, Suzhou 215000, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Hepatology, The Fifth People’s Hospital of Suzhou, Suzhou 215000, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaObjective: To evaluate the feasibility of automated machine learning (AutoML) in predicting 30-day mortality in non-cholestatic cirrhosis. Methods: A total of 932 cirrhotic patients were included from the First Affiliated Hospital of Soochow University between 2014 and 2020. Participants were divided into training and validation datasets at a ratio of 8.5:1.5. Models were developed on the H<sub>2</sub>O AutoML platform in the training dataset, and then were evaluated in the validation dataset by area under receiver operating characteristic curves (AUC). The best AutoML model was interpreted by SHapley Additive exPlanation (SHAP) Plot, Partial Dependence Plots (PDP), and Local Interpretable Model Agnostic Explanation (LIME). Results: The model, based on the extreme gradient boosting (XGBoost) algorithm, performed better (AUC 0.888) than the other AutoML models (logistic regression 0.673, gradient boost machine 0.886, random forest 0.866, deep learning 0.830, stacking 0.850), as well as the existing scorings (the model of end-stage liver disease [MELD] score 0.778, MELD-Na score 0.782, and albumin-bilirubin [ALBI] score 0.662). The most key variable in the XGBoost model was high-density lipoprotein cholesterol, followed by creatinine, white blood cell count, international normalized ratio, etc. Conclusion: The AutoML model based on the XGBoost algorithm presented better performance than the existing scoring systems for predicting 30-day mortality in patients with non-cholestatic cirrhosis. It shows the promise of AutoML in its future medical application.https://www.mdpi.com/2075-4426/12/11/1930non-cholestatic cirrhosisautomated machine learningshapley additive explanationpartial dependence plotslocal interpretable model agnostic explanation
spellingShingle Chenyan Yu
Yao Li
Minyue Yin
Jingwen Gao
Liting Xi
Jiaxi Lin
Lu Liu
Huixian Zhang
Airong Wu
Chunfang Xu
Xiaolin Liu
Yue Wang
Jinzhou Zhu
Automated Machine Learning in Predicting 30-Day Mortality in Patients with Non-Cholestatic Cirrhosis
Journal of Personalized Medicine
non-cholestatic cirrhosis
automated machine learning
shapley additive explanation
partial dependence plots
local interpretable model agnostic explanation
title Automated Machine Learning in Predicting 30-Day Mortality in Patients with Non-Cholestatic Cirrhosis
title_full Automated Machine Learning in Predicting 30-Day Mortality in Patients with Non-Cholestatic Cirrhosis
title_fullStr Automated Machine Learning in Predicting 30-Day Mortality in Patients with Non-Cholestatic Cirrhosis
title_full_unstemmed Automated Machine Learning in Predicting 30-Day Mortality in Patients with Non-Cholestatic Cirrhosis
title_short Automated Machine Learning in Predicting 30-Day Mortality in Patients with Non-Cholestatic Cirrhosis
title_sort automated machine learning in predicting 30 day mortality in patients with non cholestatic cirrhosis
topic non-cholestatic cirrhosis
automated machine learning
shapley additive explanation
partial dependence plots
local interpretable model agnostic explanation
url https://www.mdpi.com/2075-4426/12/11/1930
work_keys_str_mv AT chenyanyu automatedmachinelearninginpredicting30daymortalityinpatientswithnoncholestaticcirrhosis
AT yaoli automatedmachinelearninginpredicting30daymortalityinpatientswithnoncholestaticcirrhosis
AT minyueyin automatedmachinelearninginpredicting30daymortalityinpatientswithnoncholestaticcirrhosis
AT jingwengao automatedmachinelearninginpredicting30daymortalityinpatientswithnoncholestaticcirrhosis
AT litingxi automatedmachinelearninginpredicting30daymortalityinpatientswithnoncholestaticcirrhosis
AT jiaxilin automatedmachinelearninginpredicting30daymortalityinpatientswithnoncholestaticcirrhosis
AT luliu automatedmachinelearninginpredicting30daymortalityinpatientswithnoncholestaticcirrhosis
AT huixianzhang automatedmachinelearninginpredicting30daymortalityinpatientswithnoncholestaticcirrhosis
AT airongwu automatedmachinelearninginpredicting30daymortalityinpatientswithnoncholestaticcirrhosis
AT chunfangxu automatedmachinelearninginpredicting30daymortalityinpatientswithnoncholestaticcirrhosis
AT xiaolinliu automatedmachinelearninginpredicting30daymortalityinpatientswithnoncholestaticcirrhosis
AT yuewang automatedmachinelearninginpredicting30daymortalityinpatientswithnoncholestaticcirrhosis
AT jinzhouzhu automatedmachinelearninginpredicting30daymortalityinpatientswithnoncholestaticcirrhosis